Extended-Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention

Stephanie E. Barrett, Ryan S. Teller, Seth Forster, +15

Antimicrobial Agents and Chemotherapy

Vaccine Hesitancy: COVID-19 and Influenza Vaccine Willingness among Parents in Wuxi, China—A Cross-Sectional Study

Qiang Wang, Shixin Xiu, Shuangyu Zhao, +15

Vaccines

Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection

Yao Lin, Guolin Wang, Yuan Shen, +12

The Journal of Infectious Diseases

A Novel Strategy for the Detection of SARS-CoV-2 Variants Based on Multiplex PCR-Mass Spectrometry Minisequencing Technology

Fei Zhao, Jinxing Lu, Bing Lu, +12

Microbiology Spectrum

Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent

Raju Subramanian, Jennifer Tang, Jim Zheng, +17

Molecular Pharmaceutics

Pharmaceutical SciencePharmacokinetic ModelingFlip-flop KineticsMedicineImmunology +12

<i>In Vitro</i> Evaluation of the Drug Interaction Potential of Doravirine

Kelly Bleasby, Kerry L. Fillgrove, Robert Houle, +6

Antimicrobial Agents and Chemotherapy

Chronic exposure to microcystin-LR reduces thyroid hormone levels by activating p38/MAPK and MEK/ERK signal pathway

Jihai Chen, Rongwen Bian, Li Jiang, +3

Ecotoxicology and Environmental Safety

Signal TransductionEndocrine MechanismMicrocystin-lr ReducesMek/erk Signal PathwayMedicine +8

Characteristics and evaluation of the effectiveness of monitoring and control measures for the first 69 Patients with COVID-19 from 18 January 2020 to 2 March in Wuxi, China

Ping Shi, Yumeng Gao, Yuan Shen, +8

Sustainable Cities and Society

Preventive MedicineVirus EpidemiologyCovid-19 PandemicPatient SafetyJanuary 2020 +8

Delays in routine childhood vaccinations and their relationship with parental vaccine hesitancy: a cross-sectional study in Wuxi, China

Qiang Wang, Shixin Xiu, Liuqing Yang, +9

Expert Review of Vaccines

539. GS-CA2: A Novel, Potent, and Selective First-In-class Inhibitor of HIV-1 Capsid Function Displays Nonclinical Pharmacokinetics Supporting Long-Acting Potential in Humans

Jim Zheng, Stephen R. Yant, Shekeba Ahmadyar, +12

Open Forum Infectious Diseases

Gs-ca2 Plasma ConcentrationsMedicineHuman RetrovirusImmunologyGs-ca2 Pk Parameters +13